News and Events

Follow our latest news and events that we are participating in.

More about us

Seminar: ”Manage risk and build value in early clinical development”

Save the date: 12thMarch
In a close partnership, Immuneed and CTC Clinical Trial Consultants offer a total solution for the preclinical and clinical characterisation of your drug. By using a unique approach, we help you manage risk and build value in your early clinical development. Join our seminar and learn more about the preclinical human model.

Read more

Atlas of Science published a summary of our Immuno-Service

Atlas of Science published a summary of our Immuno-Service
Read more: http://atlasofscience.org/profiling-biologics-in-circulating-human-whole-blood/

Read more

Immuneed AB relocates to Uppsala Science Park

Immuneed AB, a Swedish biotech company, announced today that the company premises are moving from Dag Hammarskjölds väg 13 to Uppsala Science Park at Dag Hammarskjölds väg 10. Strategic relocation is an important step for the company’s continued growth and development in the field of immuno-service. Immuneed’s new facilities are located in the heart of Uppsala’s rapidly developing pharma and biotech community.

Read more

We are excited about the upcoming European Antibody Congress in Basel! Will you be there? Come and meet us at stand no.26

Join us at EuropeanAntibody Congress that takes place in Congress Centre, Basel, Switzerland,29-31 October 2018.

Read more

Ultimovacs acquires the immunotherapy technology business of Immuneed AB for NOK 50 million

The Norwegian biotech company Ultimovacs AS took over the immunotherapy technology business of the Swedish company Immuneed AB last month. The complementary technologies of the two companies provide a unique platform for development of novel vaccine solutions for treatment and possibly prevention of cancer. 

Read more

Immuneed AB appoints new CEO to strengthen immuno-service business growth and expansion

Immuneed AB, a Swedish biotech service company, today announced that Charlotte Leife has been appointed as the company’s new Chief Executive Officer (CEO). The recruitment is a result of Immuneed’s rigorous growth and an important step in the company’s evolution into a global service provider. Immuneed will henceforth exclusively focus on immuno-service and promotion of its unique human whole-blood loop assay.

Read more

Quick Links

Dag Hammarskjölds väg 10B | 752 37 Uppsala, Sweden | info@immuneed.com

Skip to toolbar Log Out